NCT00442793View on ClinicalTrials.gov

A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.

PHASE3CompletedINTERVENTIONAL

Enrollment

265

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Anemia

Interventions

DRUG

Epoetin beta

As prescribed, 3 times weekly

DRUG

methoxy polyethylene glycol-epoetin beta [Mircera]

0.4 micrograms/kg iv every 2 weeks

Trial Locations (14)

10029

Beijing

100050

Beijing

100853

Beijing

200001

Shanghai

200003

Shanghai

200025

Shanghai

200032

Shanghai

200040

Shanghai

210009

Nanjing

310003

Hangzhou

510515

Guangzhou

610072

Chengdu

Unknown

Guangzhou

Hong Kong

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00442793 - A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease. | Biotech Hunter | Biotech Hunter